Jane Street’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,821,790
| Closed | -$7.87M | – | 12752 |
|
|
2026
Q1 | $7.05M | Buy |
+1,821,790
| New | +$7.47M | ﹤0.01% | 3004 |
|
|
2025
Q4 | – | Sell |
-406,403
| Closed | -$1.57M | – | 12074 |
|
|
2025
Q3 | $1.34M | Buy |
406,403
+156,872
| +63% | +$443K | ﹤0.01% | 5716 |
|
|
2025
Q2 | $354K | Buy |
+249,531
| New | +$355K | ﹤0.01% | 7555 |
|
|
2025
Q1 | – | Sell |
-14,057
| Closed | -$22.1K | – | 10330 |
|
|
2024
Q4 | $15.7K | Sell |
14,057
-51,025
| -78% | -$43.5K | ﹤0.01% | 9151 |
|
|
2024
Q3 | $61.6K | Sell |
65,082
-59,003
| -48% | -$74.4K | ﹤0.01% | 9130 |
|
|
2024
Q2 | $196K | Buy |
124,085
+32,142
| +35% | +$46.7K | ﹤0.01% | 8399 |
|
|
2024
Q1 | $133K | Sell |
91,943
-114,254
| -55% | -$164K | ﹤0.01% | 8409 |
|
|
2023
Q4 | $276K | Buy |
206,197
+173,228
| +525% | +$204K | ﹤0.01% | 7722 |
|
|
2023
Q3 | $46.8K | Buy |
+32,969
| New | +$46.7K | ﹤0.01% | 8166 |
|
|
2023
Q2 | – | Sell |
-18,319
| Closed | -$19.4K | – | 9356 |
|
|
2023
Q1 | $19.4K | Buy |
+18,319
| New | +$26.4K | ﹤0.01% | 8655 |
|
|
2022
Q3 | – | Sell |
-229,441
| Closed | -$484K | – | 10257 |
|
|
2022
Q2 | $307K | Buy |
229,441
+171,209
| +294% | +$254K | ﹤0.01% | 7576 |
|
|
2022
Q1 | $123K | Sell |
58,232
-3,340
| -5% | -$8.13K | ﹤0.01% | 9349 |
|
|
2021
Q4 | $229K | Buy |
61,572
+39,189
| +175% | +$169K | ﹤0.01% | 8614 |
|
|
2021
Q3 | $112K | Buy |
+22,383
| New | +$129K | ﹤0.01% | 9234 |
|
|
2021
Q1 | – | Sell |
-26,072
| Closed | -$220K | – | 9466 |
|
|
2020
Q4 | $266K | Sell |
26,072
-53,607
| -67% | -$348K | ﹤0.01% | 6576 |
|
|
2020
Q3 | $279K | Buy |
79,679
+59,654
| +298% | +$283K | ﹤0.01% | 5985 |
|
|
2020
Q2 | $100K | Buy |
20,025
+384
| +2% | +$1.31K | ﹤0.01% | 6703 |
|
|
2020
Q1 | $67K | Sell |
19,641
-12,163
| -38% | -$52.5K | ﹤0.01% | 5046 |
|
|
2019
Q4 | $174K | Buy |
31,804
+11,911
| +60% | +$67K | ﹤0.01% | 4756 |
|
|
2019
Q3 | $114K | Buy |
+19,893
| New | +$135K | ﹤0.01% | 4778 |
|
|
2018
Q4 | – | Sell |
-146,132
| Closed | -$2.52M | – | 5508 |
|
|
2018
Q3 | $2.52M | Buy |
146,132
+127,702
| +693% | +$1.9M | 0.01% | 1671 |
|
|
2018
Q2 | $257K | Buy |
+18,430
| New | +$311K | ﹤0.01% | 4298 |
|
|
2018
Q1 | – | Sell |
-96,582
| Closed | -$1.38M | – | 5261 |
|
|
2017
Q4 | $1.11M | Buy |
96,582
+81,658
| +547% | +$1.22M | ﹤0.01% | 2219 |
|
|
2017
Q3 | $284K | Buy |
+14,924
| New | +$307K | ﹤0.01% | 3755 |
|
|
2016
Q3 | – | Sell |
-36,263
| Closed | -$959K | – | 4384 |
|
|
2016
Q2 | $884K | Buy |
36,263
+28,635
| +375% | +$812K | ﹤0.01% | 2128 |
|
|
2016
Q1 | $256K | Buy |
+7,628
| New | +$240K | ﹤0.01% | 3399 |
|
|
2015
Q4 | – | Sell |
-39,414
| Closed | -$1.24M | – | 4340 |
|
|
2015
Q3 | $1.24M | Sell |
39,414
-55,067
| -58% | -$2.69M | 0.01% | 1431 |
|
|
2015
Q2 | $4.57M | Buy |
94,481
+55,797
| +144% | +$2.35M | 0.03% | 514 |
|
|
2015
Q1 | $1.68M | Buy |
+38,684
| New | +$1.39M | 0.01% | 995 |
|
|
2014
Q3 | – | Sell |
-12,737
| Closed | -$306K | – | 2930 |
|
|
2014
Q2 | $306K | Buy |
+12,737
| New | +$258K | ﹤0.01% | 1824 |
|
|
2014
Q1 | – | Sell |
-19,424
| Closed | -$442K | – | 2972 |
|
|
2013
Q4 | $442K | Buy |
+19,424
| New | +$392K | 0.01% | 1330 |
|
Other funds holding PGEN
PCM
DC
TCM
BCM
IAM
Jane Street's PGEN Position: Q2 2026 in Review
Jane Street sold out of Precigen (PGEN) in Q2 2026, closing a stake of 1,821,790 shares — an estimated $7.87M sold.
Jane Street first reported a position in PGEN in Q4 2013 and held it in 31 quarters. The position peaked at $7.05M in Q1 2026. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- Jane Street reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 1,821,790 Precigen shares in Q2 2026, an estimated $7.87M.
- Jane Street first reported a position in Precigen in Q4 2013 and held it in 31 quarters.
- Jane Street's Precigen position peaked at $7.05M in Q1 2026.
- 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.